Back

Baseline characteristics of edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation in China (ETNA-AF-China)

17 April 2023 (13:55 - 14:50)
Organised by:
Congress Presentation Part of: ePoster session 28 Oral Anticoagulation EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Mengqi Liu

(China)

8 More presentations in this session

Presentation thumbnail
Detection of the most dominant drivers of atrial fibrillation based on repetitive activity in sequential electro-anatomical mapping
Doctor B. Hermans (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Evaluation of redo procedures in blanking period following atrial fibrillation catheter ablation
Doctor C. Coteli (Ankara, TR)
Abstract Slides
Presentation thumbnail
Impact of the individual relationship between focal or rotational regions of interest and atrial cardiomyopathy in patients with chronic forms of atrial fibrillation
Doctor D. Guckel (Bad Oeynhausen, DE) Professor C. Sohns (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Double rhythm mapping for coherent electrophysiological substrate characterization in atrial fibrillation patients
Doctor C. Ceriotti (Rozzano, IT)
Abstract Slides
Presentation thumbnail
Increasing comorbidity burden of patients undergoing catheter ablation for atrial fibrillation in the past 10 years: An analysis of more than 8000 left-atrial ablation procedures
Doctor J. Obergassel (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 28

The Event

Event poster

EHRA 2023

17 April 2023 13:55 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources